The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials

on behalf of AME Lung Cancer Collaborative Group, written; Xu, Yangyang; Wan, Bing; Chen, Xi; Zhan, Ping; Zhao, Yuan; Zhang, Tianli; Liu, Hongbing; Zubair Afzal, Muhammad; Dermime, Said; N. Hochwald, Steven; Hofman, Paul; Borghaei, Hossein; Lin, Dang; Lv, Tangfeng; Song, Yong‐Seok

doi:10.21037/tlcr.2019.08.09

Public

The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials

Published in Translational Lung Cancer Research • Aug 1, 2019

Authors:

written on behalf of AME Lung Cancer Collaborative Group

Yangyang Xu

Bing Wan

Abstract

Background: We conducted a meta-analysis to evaluate the efficacy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) monotherapy or immunotherapy combined with chemotherapy and further estimated the value of PD-L1 expression in predicting the response from anti-PD-1/PD-L1 ...

Subject

Medicine

Internal medicine

Lung cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!